Zim laboratories appears to have given a break out. Since listing in 2019, it made a high of 124.35 and today it has decisively taken out the previous highs. RSI and MACD indicating price strength and momentum above short, medium and long term moving averages. One may add this to their watchlist.
As far as the fundamentals are concerned the stock currently valued at good expensive valuation.
3 years CAGR Growth
1) Revenue 12.8%
2) Operating profit margin- 32%
3) Net profit - 95%
As far as the fundamentals are concerned the stock currently valued at good expensive valuation.
3 years CAGR Growth
1) Revenue 12.8%
2) Operating profit margin- 32%
3) Net profit - 95%
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。